Navigation Links
Treating Alzheimer's disease with Yizhijiannao granules by inhibiting neuronal apoptosis
Date:8/13/2014

Previous studies have shown that Yizhijiannao granule can enhance cognitive performance in Alzheimer's disease patients and Alzheimer's disease-model mice. Further studies revealed that Yizhijiannao granule may exert its therapeutic effect by inhibiting neural cell apoptosis, reducing tau phos-phorylation and relieving neuroinflammation. Dr. Hong Zhu and colleagues who come from Third Xiangya Hospital of Central South University, China treated senescence-accelerated mouse prone 8 mice with Yizhijiannao granule, aiming to identify target-proteins of Yizhijiannao granule that were particularly related to the treatment of Alzheimer's disease. Thirty-seven differential protein spots were found in the temporal lobe area, and finally 10 protein spots were identified. These proteins are separately involved in the regulation of amyloid beta production, oxidative stress, neuroinflammation, regulation of tau phosphorylation, and regulation of neuronal apoptosis. The relevant study has been published in the Neural Regeneration Research (Vol. 9, No. 13, 2014).


'/>"/>

Contact: Meng Zhao
eic@nrren.org
86-138-049-98773
Neural Regeneration Research
Source:Eurekalert  

Page: 1

Related biology news :

1. Toward an oral therapy for treating Alzheimers disease: Using a cancer drug
2. Endocrine Press publishes guide to treating metabolic emergencies
3. Mechanism of cell death unraveled -- perspectives for treating inflammatory diseases
4. Marijuana shows potential in treating autoimmune disease
5. A new approach to treating peanut and other food allergies
6. Grape skin extract may soon be answer to treating diabetes
7. Mouse study points to potentially powerful tool for treating damaged hearts
8. Two researchers known for identifying and treating bubble boy disease honored by March of Dimes
9. Discovery leads to patent for novel method of treating traumatic brain injury
10. Worms and hot baths: Novel approaches to treating autism
11. Old drug may teach new tricks in treating infectious diseases, cancer
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Treating Alzheimer's disease with Yizhijiannao granules by inhibiting neuronal apoptosis
(Date:4/19/2016)... 20, 2016 The new GEZE ... compact web-based "all-in-one" system solution for all door components. ... or the door interface with integration authorization management system, ... systems. The minimal dimensions of the access control and ... building installations offer considerable freedom of design with regard ...
(Date:4/14/2016)... Israel , April 14, 2016 ... Authentication and Malware Detection, today announced the appointment of ... assumed the new role. Goldwerger,s leadership appointment ... on the heels of the deployment of its platform ... BioCatch,s behavioral biometric technology, which discerns unique cognitive and ...
(Date:3/31/2016)... March 31, 2016  Genomics firm Nabsys has completed ... Barrett Bready , M.D., who returned to the ... original technical leadership team, including Chief Technology Officer, ... Development, Steve Nurnberg and Vice President of Software and ... company. Dr. Bready served as CEO of ...
Breaking Biology News(10 mins):
(Date:5/19/2016)... YORK , May 19, 2016 ... space will fully recover given the relentless pressures in ... for sure in the investors circle though - numerous ... due-diligence. Ahead of today,s session, ActiveWallSt.com,s presents four names ... PTLA ), Vitae Pharmaceuticals Inc. (NASDAQ: VTAE ...
(Date:5/19/2016)... 2016 Regen BioPharma, ... RGBPP) announced today initiation of a preclinical development ... based cancer immunotherapeutic product leveraging its NR2F6 immunological ... a generation of cord blood derived killer cells ...  The product in development will be a "universal ...
(Date:5/18/2016)... ... May 18, 2016 , ... Tech Coast Angels ... Villalobos Award to Cognition Therapeutics at the annual ACA Summit last week in Philadelphia. ... financed by one of ACA’s member angel groups. It is the highest honor available ...
(Date:5/18/2016)... , May 18, 2016 The ... it does not mean that there are no opportunities ahead. ... Pharmaceuticals Inc. (NASDAQ: THLD ), Seattle Genetics Inc. ... CHMA ), and Ophthotech Corp. (NASDAQ: OPHT ). ... alerts at: http://www.activewallst.com/ Threshold ...
Breaking Biology Technology: